Gene-Gene and Gene-Clinical Factors Interaction in Acute Myocardial Infarction: A New Detailed Risk Chart

E-ISSN： 1873-4286|16|7|783-788

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.7, 2010-03, pp. : 783-788

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A New Risk Chart of Acute Myocardial Infarction in Men by an Innovative Algorithm: A Pilot Study

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 3, 2015-03 ,pp. : 159-166

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Angiotensin Receptor Blockade on Haemodynamics and Gene Expression after Myocardial Infarction

By Gurevich A.K.

Drugs in R&D, Vol. 3, Iss. 4, 2002-01 ,pp. : 239-249

Adis International

Access to resources Recommend Favorite

Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics

Current Pharmaceutical Design, Vol. 14, Iss. 26, 2008-09 ,pp. : 2678-2685

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction - VEGF gene therapy for myocardial infarction

By Bull D.A. Bailey S.H. Rentz J.J. Zebrack J.S. Lee M. Litwin S.E. Kim S.W.

Journal of Controlled Release, Vol. 93, Iss. 2, 2003-12 ,pp. : 175-181

Elsevier

Access to resources Recommend Favorite

Association of Thrombospondin-1 (N700S) and Thrombospond in-4 (A387P) Gene Polymorphisms with the Incidence of Acute Myocardial Infarction in Egyptians

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 13, 2018-03 ,pp. : 1078-1087

Bentham Science Publishers

Access to resources Recommend Favorite